HCL Tech shares jump over 7% post Q4 earnings


Representational image of HCLTech office in Lucknow

Representational image of HCLTech office in Lucknow
| Photo Credit: Reuters

Shares of HCL Technologies on Wednesday (April 23, 2025) surged over 7% after the firm posted an 8.1% increase in consolidated net profit for the January-March quarter of 2024-25.

The stock jumped 7.42% to ₹1,589.95 on the BSE. At the NSE, shares of the firm rallied 7.43% to ₹1,590 apiece.

The stock emerged as the biggest gainer among the BSE Sensex and NSE Nifty firms during morning trade.

HCL Technologies on Tuesday posted an 8.1 per cent increase in consolidated net profit at ₹4,307 crore for the March quarter 2024-25, mainly on account of large deals with a total contract value of about ₹25,500 crore.

The company had logged a profit of ₹3,986 crore for the same period a year ago, it said in a regulatory filing.

“We grew 2.9% on a year-on-year basis. Our operating margin for the quarter came in at 17.9%. Our services business grew 0.7% sequentially and 2.7% year-on-year,” HCL Tech CEO and Managing Director C Vijayakumar said.

Revenue from operations increased 6.1% to ₹30,246 crore in the quarter under review, from ₹28,499 crore in the March quarter 2023-24.

Vijayakumar said that the company bagged deals worth $3 billion (around ₹25,500 crore).

“We had a very strong quarter. In fact, the second highest after the September 23 quarter, which was on the back of a mega deal, which all of you know.

“This quarter, we brought in $3 billion in net new booking. At the fiscal year level, the total new booking stood at $9.4 billion. The strong booking was well-balanced across service lines, geographies, and verticals,” he said.

For the year ended March 31, 2025, HCL Technologies posted an increase of about 11 per cent in net profit at ₹17,390 crore, from ₹15,710 crore in FY24.

Revenue from operations rose 6.5% to ₹1,17,055 crore year-on-year.



Source link

  • Related Posts

    Lupin, China’s SUP ink pact for COPD drug Tiotropium DPI

    Lupin has signed a license and supply agreement with Sino Universal Pharmaceuticals (SUP) for commercialisation of chronic obstructive pulmonary disease drug Tiotropium Dry Powder Inhaler, 18 mcg/capsule, in the Chinese…

    Continue reading
    India to export 150 locomotives to Africa worth over ₹3,000 crore

    “These locomotives are fitted with Distributed Power Wireless Control System, or DPWCS, for synchronised operations and superior freight handling,” a Railways Ministry spokesperson said. Photo: https://www.wabteccorp.com/ India will supply 150…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *